Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnimalcare Grp Regulatory News (ANCR)

Share Price Information for Animalcare Grp (ANCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 227.00
Bid: 220.00
Ask: 234.00
Change: -9.00 (-3.81%)
Spread: 14.00 (6.364%)
Open: 236.00
High: 236.00
Low: 227.00
Prev. Close: 236.00
ANCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

9 Feb 2015 07:00

RNS Number : 3519E
Animalcare Group PLC
09 February 2015
 



 

Animalcare Group plc

("Animalcare" or the "Group")

Directorate Change

 

Animalcare (AIM: ANCR), a leading supplier of veterinary medicines, announces the appointment of George Gunn as a Non-Executive Director of the Group with immediate effect.

 

Mr Gunn stepped down recently as Head of the Animal Health Division and from the Executive Committee of Novartis AG on completion of the sale of that division on 1st January 2015. He has extensive experience in Animal Health Pharmaceuticals over a career that has spanned 30 years within the industry including the Wellcome Foundation, Janssen Pharmaceutical, Pharmacia Corporation and Novartis, where he has worked since 2003. In his early career Mr Gunn worked as a Veterinary Practitioner in Scotland before joining the Ministry of Agriculture as a Veterinary officer advising on notifiable disease issues.

 

Mr Gunn is a qualified veterinary surgeon, a Member of the Royal College of Veterinary Surgeons and has an Honorary Doctorate in Veterinary Medicine and Surgery from the University of Edinburgh. Mr Gunn is a past-Chairman of the National Office of Animal Health (NOAH) and past-President of the International Federation of Animal Health (IFAH).

 

James Lambert, Chairman, commented: "I am very pleased to welcome George Gunn on to the board of Animalcare. George's achievements in animal health are extensive and impressive in equal measure. George will complement the skills of the existing board members and bring additional commercial and product development experience to the team to help deliver our strategy. We are very excited by the additional momentum provided by George's appointment and believe the future is looking bright for the business."

 

 

For further information, please contact:

 

Animalcare Group plc

Tel: 01904 487 687

Iain Menneer, Chief Executive Officer

Chris Brewster, Chief Financial Officer

Panmure Gordon (Nominated Adviser and Broker)

Freddy Crossley/Peter Steel

Tel: 020 7886 2500

Walbrook PR Ltd

Tel: 020 7933 8780 or animalcare@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

Appendix 1: disclosures required pursuant to Rule 17 and Schedule 2(g) of the AIM Rules

 

George William Gunn (aged 64) has, during the past five years been a director of the following companies:

 

Novartis Centre de Recherche Santé Animale SA

Novartis Consumer Health AG

Novartis Consumer Health Schweiz AG

Novartis Animal Health US, Inc.

Novartis Animal Health UK Limited

Novartis Animal Vaccines Limited

Novartis Sanidad Animal S.L.

Vericore Holdings Limited

Vericore Limited

 

Save as set out in this announcement, there are no further details to be disclosed under Rule 17 or Schedule 2(g) of the AIM rules in respect of Mr Gunn.

 

 

About Animalcare: www.animalcaregroup.co.uk

 

Animalcare is a leading veterinary sales and marketing company based in York with 57 employees including a field sales force of 14 representatives selling to all veterinary practices around the United Kingdom.

 

Animalcare has developed a range of generic veterinary medicines and animal identification products primarily to companion animal veterinary markets.  

 

Animalcare operates in three product areas:

 

· Licensed Veterinary Medicines - a range of branded veterinary licensed pharmaceuticals sold to veterinary professionals in the UK and selected markets in Northern Europe. The range can be divided into four main categories; antibacterials, anaesthetics & analgesics, Aqupharm intravenous fluids and vitamins & speciality pharmaceuticals.

 

· Companion Animal Identification - Identichip is the pioneering microchip identification system in the UK. Animalcare also owns and operates the Anibase database; together the market leader in electronic identification for pets in the UK.

 

· Animal Welfare Products - a range used by veterinary professionals in the diagnosis and care of their patients, for example intravenous infusion accessories, ophthalmic instruments, hygiene solutions and bandages and dressings.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGUWAPUPAGGR
Date   Source Headline
12th Jul 202111:04 amRNSNotification of Major Holding
12th Jul 20217:00 amRNSExercise of options
9th Jul 20214:59 pmRNSNotification of Major Holding
9th Jul 20213:20 pmRNSNotification of Major Holding
8th Jul 20215:45 pmRNSResult of Secondary Placing
8th Jul 20214:41 pmRNSSecond Price Monitoring Extn
8th Jul 20214:35 pmRNSPrice Monitoring Extension
8th Jul 20212:06 pmRNSSecond Price Monitoring Extn
8th Jul 20212:00 pmRNSPrice Monitoring Extension
8th Jul 20211:00 pmRNSProposed Secondary Placing
1st Jul 20217:00 amRNSTotal Voting Rights
21st Jun 20217:00 amRNSExercise of options
17th Jun 202110:17 amRNSDirector/PDMR Notification
10th Jun 20214:41 pmRNSSecond Price Monitoring Extn
10th Jun 20214:35 pmRNSPrice Monitoring Extension
9th Jun 20215:03 pmRNSResult of 2021 AGM
17th May 20217:00 amRNSAnnual Report 2020 and Notice of AGM
22nd Apr 20217:00 amRNSDaxocox approved by EU and UK authorities
30th Mar 20217:00 amRNSFull Year Results 2020
23rd Mar 20217:00 amRNSNotification of major holding
18th Feb 20214:36 pmRNSPrice Monitoring Extension
18th Feb 20213:43 pmRNSDaxocox receives positive opinion from CVMP in EU
8th Feb 20212:46 pmRNSNotification of major holding
1st Feb 20217:00 amRNSAppointment of Nominated Advisor and Joint Broker
21st Jan 20217:00 amRNSTrading Update and Notice of Full Year Results
18th Nov 20207:00 amRNSGrant of options
29th Sep 20207:00 amRNSInterim Results H1 2020
28th Sep 20207:00 amRNSAnimalcare and Kane Biotech to target biofilms
23rd Jul 20207:00 amRNSTrading Update and Notice of Results
30th Jun 20204:00 pmRNSResult of AGM 2020
9th Jun 20203:55 pmRNS2019 Annual Report and Notice of 2020 AGM
28th May 20207:00 amRNSFull year results 2019
18th May 202011:20 amRNSNotice of Full Year 2019 Results
25th Mar 20207:00 amRNSTrading update, revised date for full year results
23rd Jan 20207:00 amRNSTrading Update & Notice of Results
17th Jan 20208:55 amRNSHoldings in Company
24th Sep 20197:00 amRNSHalf Year Results
25th Jul 20197:00 amRNSDirectorate Change
23rd Jul 20197:00 amRNSTrading Update & Notice of Results
16th Jul 201911:37 amRNSNotification of major holdings
25th Jun 20191:40 pmRNSResult of AGM
19th Jun 20193:52 pmRNSBoard change
10th Jun 20192:55 pmRNSDirector/PDMR Shareholding
22nd May 20197:00 amRNSAnnual Report and Notice of Annual General Meeting
8th May 201910:35 amRNSDividend Declaration
30th Apr 20197:00 amRNS2018 Full Year Results
21st Jan 20197:00 amRNSTrading Update and Notice of Results
30th Oct 20187:50 amRNSAdditional Listing
1st Oct 201812:45 pmRNSAdditional Listing
25th Sep 20185:36 pmRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.